Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Biotechnology

Health Care

Pharmaceutical

Promentis Pharmaceuticals

Promentis Pharmaceuticals' headquarters in Milwaukee, WI, United States

Chad E. Beyer

Stacy Holland

Michael P. Neary

Jon E. Grant

Klaus Veitinger

David A. Baker

Robert Weisskoff

Tim Keane

Darin D. Dougherty

Patrick Schwarz-Schuette

Daniel C. Javitt

Peter W. Kalivas

The Research and Development team at Promentis Pharmaceuticals is responsible for driving innovative research to discover and develop novel antipsychotic medications. This team collaborates closely across scientific disciplines to design and conduct preclinical and clinical trials, ensuring the safety and efficacy of new treatments for schizophrenia. Their efforts are pivotal in advancing therapeutic options and improving patient outcomes.

Research and Development

The Leadership Team at Promentis Pharmaceuticals is responsible for guiding the company's strategic direction and ensuring the effective development and commercialization of antipsychotic drugs. This team collaborates to align financial resources, oversee research initiatives, and drive innovation in treatments for schizophrenia, while maintaining regulatory compliance and optimizing operational efficiency.

Leadership Team

Promentis Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Promentis Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies